Ownership history in Qube Research & Technologies Ltd Β· 17 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in CONSTELLIUM SE (CSTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Qube Research & Technologies Ltd outperformed the S&P 500 by +7.8% annually on this CSTM position. Timing score: 50% (8/16 decisions correct). Average cost basis: $17.24. Maximum drawdown during holding period: β54.4%.
π₯ Exceptional β beat the S&P 500 by 7.8% per year on this position.
16 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
8 of 16 add/trim decisions correct
Best entry: $7.68 (2020 Q2) Β· Worst: $22.11 (2024 Q1)
πͺ Held through 2 major drawdowns (>20%).
10 adds Β· 7 trims. Bought during 4 of 6 down-price quarters. π More buys than sells across the holding period.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size